Bidirectional Link Seen for Psychiatric Disorders With Chronic Rhinosinusitis
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 16, 2024 -- There is a bidirectional association for anxiety and depression with chronic rhinosinusitis (CRS), according to a study published online Sept. 12 in JAMA Otolaryngology-Head & Neck Surgery.
Najm S. Khan, from Houston Methodist Hospital, and colleagues examined the bidirectional risk for anxiety and depression for patients with CRS in a retrospective cohort study of the National Institutes of Health All of Us database from Jan. 1, 2008, to Dec. 31, 2018. Two cohorts of adults with and without CRS were included. Patients with CRS were propensity score-matched (1:5) to those without CRS for age, sex, race, and annual household income; the analyses included 5,622 patients with CRS and 28,110 controls.
The researchers found that patients with CRS had higher odds of having anxiety (odds ratio, 4.39) and depression (odds ratio, 2.04) and had an increased risk for developing anxiety (hazard ratio [HR], 2.79) and depression (HR, 1.40) compared with controls. Compared with controls, patients with anxiety (HR, 2.37) and depression (HR, 1.59) had an increased risk for developing CRS.
"Physicians and health care clinicians who commonly treat patients with anxiety, depression, and chronic rhinosinusitis should be vigilant regarding these risks and screen patients accordingly," the authors write.
Sevpsycheral authors disclosed ties to the biopharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Prevalence of Anxiety, Depression Explored in Youth With Chronic Pain
MONDAY, Sept. 16, 2024 -- Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their peers without chronic pain...
Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022
MONDAY, Sept. 16, 2024 -- Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased...
Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and Older
FRIDAY, Sept. 13, 2024 -- For persons diagnosed with HIV (PWH) aged 50 years and older, progress on quality of life (QoL) goals is limited, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.